MEDIGEN VACCINE BIOLOGICS CORPORATE financial statements, including revenue, expenses, profit, and loss
The total revenue of 6547 for the last quarter is 58.60 M TWD, and it's 65.80% lower compared to the previous quarter. The net income of Q1 24 is -73.42 M TWD.